ANIP Stock Balance Sheets

ANI Pharmaceuticals Quarterly Balance Sheets Chart

Quarterly

Annual

Goodwill

Cash and Cash Eq

Account Payables

Deferred Revenue

Inventory

ANI Pharmaceuticals Quarterly Balance Sheets Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2013-12-31	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-06-30

current assets
cash and cash equivalents	217,797,000	149,802,000	144,861,000	144,982,000	240,110,000	228,597,000	221,121,000	193,078,000	161,707,000	67,757,000	48,228,000	56,281,000	63,385,000	76,911,000	100,300,000	15,254,000	24,261,000	25,073,000	7,864,000	17,900,000	27,702,000	20,414,000	62,332,000	59,673,000	40,589,000	38,233,000	43,008,000	44,136,000	54,994,000	51,970,000	31,144,000	18,031,000	8,369,000	10,826,000	27,365,000	16,155,000	15,014,000	77,747,000	154,684,000	150,913,000	166,731,000	165,563,000	169,037,000	35,050,000	52,961,000	11,105,000	29,388,772		38,049,095	42,417,045	49,473,732		69,600,199	37,126,006	51,349,021	38,155,251	35,526,017	46,382,112	41,163,001	29,858,465	13,169,258	5,985,823	10,162,346	11,760,920	5,700,697	10,325,577	15,648,948	25,402,564	27,382,168	11,290,742	7,653,852	366,174	133,605	70,189	310,643	379,523
restricted cash	36,000	34,000	33,000	35,000								5,003,000	5,001,000	5,000,000	5,001,000	5,001,000	5,001,000	5,000,000	5,003,000	5,003,000	5,002,000	5,002,000	5,029,000	5,025,000	5,018,000	5,008,000	5,021,000	5,014,000	5,007,000	5,002,000	5,006,000	5,004,000	5,002,000	5,001,000	5,002,000	5,001,000	5,001,000										2,260,100
accounts receivable, net of 120,421 and 127,824 of adjustments for chargebacks and other allowances at june 30, 2025 and december 31, 2024, respectively	225,654,000
inventories	138,315,000	137,408,000	136,782,000	148,042,000	125,448,000	113,837,000	111,196,000	106,590,000	104,323,000	103,654,000	105,355,000	95,893,000	92,545,000	83,155,000	81,693,000	61,684,000	67,634,000	59,927,000	60,803,000	59,195,000	52,563,000	52,902,000	48,163,000	46,174,000	45,296,000	42,032,000	40,503,000	40,006,000	37,756,000	34,294,000	37,727,000	38,478,000	42,307,000	45,893,000	26,183,000	28,261,000	25,052,000	13,922,000	13,387,000	13,741,000	12,701,000	10,737,000	7,518,000	7,346,000	5,912,000	3,518,000
prepaid expenses and other current assets	15,110,000	23,326,000	17,975,000	17,475,000	14,001,000	16,050,000	17,400,000	10,690,000	8,248,000	6,874,000	8,387,000	4,972,000	6,026,000	7,726,000	7,589,000	4,702,000	4,881,000	5,922,000	5,861,000	3,358,000	3,117,000	2,967,000	3,995,000	5,025,000	3,311,000	4,157,000	4,524,000	5,004,000	1,768,000	2,267,000	2,784,000	4,847,000	2,676,000	3,565,000	3,564,000	2,653,000	4,046,000	1,252,000	1,453,000	1,985,000	1,615,000	1,546,000	1,983,000
investment in equity securities	5,718,000	5,386,000	6,307,000	8,298,000	6,943,000	9,655,000
total current assets	602,630,000	536,290,000	527,684,000	521,297,000	555,460,000	540,557,000	519,816,000	497,220,000	459,311,000	364,753,000	344,261,000	309,377,000	322,399,000	301,399,000	321,775,000	191,384,000	191,799,000	182,798,000	170,321,000	165,819,000	156,544,000	158,662,000	187,695,000	182,386,000	168,912,000	151,832,000	152,877,000	156,793,000	152,367,000	143,394,000	131,605,000	125,582,000	112,856,000	106,981,000	103,007,000	95,475,000	79,824,000	116,552,000	192,583,000	197,522,000	208,948,000	202,993,000	203,478,000	57,565,000	67,160,000	27,716,000										40,625,130
non-current assets
property and equipment	59,247,000	58,179,000	56,863,000	56,704,000	51,640,000	48,526,000	44,593,000	44,189,000	44,371,000	70,553,000	75,958,000	72,935,000	71,042,000	77,677,000	75,627,000	60,816,000	60,336,000	59,541,000	41,269,000	40,444,000	39,937,000	40,353,000	40,551,000	39,754,000	38,953,000	38,425,000	38,090,000	37,418,000	22,842,000	21,882,000	20,403,000	17,387,000	14,966,000	12,897,000	10,998,000	9,716,000	8,911,000	8,415,000	7,131,000	5,833,000	5,249,000	5,281,000	5,223,000			4,537,000			1,184,764	862,439	884,301		854,989	1,132,519	812,962		646,500	683,800	710,395	747,979	720,403	752,970	786,303	814,894	529,301	162,481	54,896	43,783	58,520	104,124	137,040	169,529	164,906	188,629	215,566	241,806
deferred tax assets, net of deferred tax liabilities and valuation allowance	92,025,000	88,489,000	85,106,000	67,661,000	89,506,000	87,607,000	90,711,000	84,389,000	81,500,000	80,956,000	81,363,000	77,340,000	76,587,000	73,539,000	67,936,000	60,196,000	58,526,000	52,006,000	51,704,000	48,130,000	53,488,000	57,906,000	38,326,000	36,002,000	31,957,000	28,542,000	27,964,000	25,082,000	23,590,000
intangible assets	520,320,000	538,495,000	541,834,000	569,825,000	183,078,000	196,044,000	209,009,000	219,828,000	230,299,000	238,791,000	251,635,000	264,237,000	269,593,000	281,573,000	294,122,000	170,141,000	180,199,000	178,859,000	188,511,000	198,620,000	205,745,000	215,619,000	180,388,000	188,372,000	196,697,000	205,100,000	201,604,000	209,544,000	217,484,000	221,917,000	229,790,000	189,829,000	196,624,000	203,459,000	175,792,000	188,949,000	194,674,000	147,386,000	66,397,000	68,291,000	44,174,000	45,408,000	42,067,000	43,188,000	21,800,000	10,409,000
goodwill	60,533,000	60,662,000	59,990,000	60,426,000	28,221,000	28,221,000	28,221,000	28,221,000	28,221,000	28,221,000	28,221,000	28,221,000	28,221,000	28,188,000	27,888,000	3,580,000	3,580,000	3,580,000	3,580,000	3,580,000	3,580,000	3,580,000	3,580,000	3,580,000	3,580,000	3,580,000	3,580,000	4,180,000	1,838,000	1,838,000	1,838,000	1,838,000	1,838,000	1,838,000	1,838,000	1,838,000	1,838,000	1,838,000	1,838,000	1,838,000	1,838,000	1,838,000	1,838,000	1,838,000	1,838,000	1,838,000
derivatives and other non-current assets	8,246,000	10,313,000	12,220,000	11,464,000	12,848,000	13,569,000	12,072,000	16,067,000	15,639,000	9,228,000	11,361,000	12,102,000	5,762,000	2,434,000
total assets	1,343,001,000	1,292,428,000	1,283,697,000	1,287,377,000	920,753,000	914,524,000	904,422,000	889,914,000	859,341,000	765,224,000	760,087,000	739,110,000	751,334,000	744,846,000	771,598,000	470,454,000	480,159,000	463,843,000	461,190,000	462,581,000	465,391,000	482,232,000	456,789,000	456,775,000	446,906,000	434,390,000	430,604,000	439,443,000	424,177,000	418,019,000	412,138,000	370,469,000	359,219,000	357,138,000	322,864,000	319,379,000	307,999,000	291,588,000	285,265,000	283,276,000	270,121,000	265,985,000	263,709,000	107,637,000	95,423,000	44,500,000		38,769,000				62,380,000				44,766,650
liabilities, mezzanine equity, and stockholders’ equity
current liabilities
current debt, net of deferred financing costs	13,216,000	11,193,000	9,172,000	7,152,000	850,000	850,000	850,000	850,000	850,000	850,000	850,000	850,000	850,000	850,000	850,000	15,927,000	15,182,000	14,438,000	13,243,000	12,785,000	12,329,000	11,872,000
accounts payable	54,569,000	53,058,000	45,656,000	60,890,000	48,681,000	49,430,000	36,683,000	34,077,000	28,505,000	32,687,000	29,305,000	18,992,000	27,641,000	22,059,000	22,967,000	11,513,000	12,977,000	13,769,000	11,261,000	13,460,000	14,209,000	12,485,000	14,606,000	10,953,000	9,809,000	10,519,000	8,884,000	7,257,000	7,949,000	4,886,000	3,630,000	5,821,000	3,153,000	4,785,000	3,389,000	4,730,000	4,961,000	3,040,000	2,066,000	2,633,000	1,325,000	2,288,000	2,654,000	3,059,000	1,731,000	1,429,000	164,352		2,004,814	3,835,756	3,281,705		6,041,891	6,348,948	8,503,790		4,522,800	4,719,457	4,002,557	2,440,096	3,529,203	2,550,227	2,429,446	3,182,089	3,420,066	2,619,915	710,575	559,380	888,751	643,845	621,818	318,254	669,734	1,380,026	1,139,566	782,495
accrued royalties	36,030,000	23,713,000	22,626,000	23,447,000	20,357,000	15,475,000	16,276,000	11,975,000	9,885,000	8,957,000	9,307,000	6,585,000	6,295,000	4,998,000	6,225,000	3,996,000	4,688,000	5,310,000	6,407,000	6,088,000	6,004,000	6,285,000	5,084,000	5,527,000	6,265,000	5,440,000	8,456,000	7,455,000	8,219,000	11,361,000	12,164,000	11,741,000	11,255,000	10,331,000	11,956,000	11,769,000	8,110,000	4,632,000	606,000
accrued compensation and related expenses	32,933,000	22,297,000	37,725,000	29,777,000	16,111,000	9,526,000	23,786,000	15,328,000	11,493,000	13,051,000	10,312,000	7,745,000	5,682,000	3,265,000	8,522,000	4,539,000	4,319,000	5,533,000	6,231,000	5,993,000	5,349,000	3,151,000	3,736,000	3,494,000	2,133,000	2,454,000	3,524,000	2,773,000	1,410,000	1,495,000	2,306,000	2,009,000	1,227,000	1,135,000	1,631,000	1,426,000	1,071,000	722,000	1,188,000	1,019,000	844,000	513,000	1,348,000
accrued government rebates	32,866,000	22,644,000	18,714,000	10,693,000	12,324,000	9,509,000	12,168,000	10,923,000	11,971,000	8,607,000	10,872,000	8,745,000	9,440,000	4,557,000	5,492,000	11,713,000	8,740,000	8,672,000	7,826,000	11,678,000	9,717,000	8,030,000	8,901,000	9,184,000	10,943,000	8,552,000	8,974,000	9,014,000	5,256,000	6,471,000	7,930,000	5,755,000	3,534,000	4,655,000	5,891,000
income taxes payable	3,294,000	14,188,000	6,749,000			11,402,000	8,164,000	594,000
returned goods reserve	48,683,000	42,464,000	39,274,000	37,068,000	33,897,000	32,853,000	29,678,000	31,438,000	29,798,000	34,108,000	33,399,000	33,984,000	34,899,000	35,554,000	35,831,000	32,229,000	31,904,000	28,944,000	27,155,000	23,250,000	20,003,000	17,614,000	16,595,000	15,945,000	14,656,000	13,559,000	12,552,000	10,840,000	9,764,000	9,020,000	8,274,000	8,317,000	7,558,000	5,776,000	5,756,000	4,099,000	3,309,000	2,666,000	2,648,000	1,889,000	1,719,000	1,817,000	1,445,000	1,178,000	951,000	736,000
current contingent consideration	483,000	229,000	29,000	1,283,000	841,000	414,000	12,266,000	23,939,000	25,025,000	22,761,000
accrued expenses and other	14,761,000	12,029,000	13,735,000	17,814,000	6,917,000	7,430,000	5,606,000	5,228,000	5,338,000	4,804,000	5,394,000	4,726,000	11,505,000	8,133,000	7,563,000	4,893,000	11,582,000	2,381,000	2,456,000	2,534,000	3,066,000	4,378,000	2,362,000	3,368,000	2,423,000	3,074,000	1,707,000	2,818,000	1,863,000	2,612,000	1,571,000	2,741,000	1,565,000	2,087,000	927,000	2,016,000	770,000	1,727,000	617,000	2,221,000	1,170,000	1,897,000	1,269,000
total current liabilities	236,835,000	201,815,000	193,680,000	189,933,000	139,978,000	136,889,000	145,477,000	134,352,000	122,865,000	125,825,000	99,439,000	81,627,000	96,312,000	79,532,000	87,537,000	84,872,000	89,454,000	82,768,000	78,565,000	75,900,000	79,088,000	79,356,000	61,676,000	170,707,000	166,794,000	165,068,000	165,549,000	46,902,000	39,678,000	39,650,000	39,228,000	36,384,000	28,292,000	32,425,000	31,948,000	30,491,000	24,730,000	16,211,000	11,756,000	12,190,000	6,949,000	9,073,000	13,233,000	8,145,000	3,828,000	3,538,000		10,594,000				7,228,000				8,183,327												2,234,868	2,610,549	2,430,717	4,299,610	1,662,982	2,303,623	2,734,762	2,666,034
non-current liabilities
non-current debt, net of deferred financing costs and current component	301,484,000	305,294,000	309,108,000	312,918,000	284,394,000	284,607,000	284,819,000	285,032,000	285,244,000	285,457,000	285,669,000	285,882,000	286,095,000	286,307,000	286,520,000	186,063,000	189,525,000	168,985,000	172,443,000	175,161,000	177,879,000	188,094,000
non-current convertible notes, net of deferred financing costs	306,862,000	306,335,000	305,812,000	305,293,000
non-current contingent consideration, net of current	18,089,000	17,426,000	19,825,000				11,718,000
accrued licensor payments due	11,428,000	11,068,000	20,961,000
other non-current liabilities	6,696,000	7,020,000	5,781,000	6,944,000	4,679,000	5,055,000	4,809,000	5,259,000	4,731,000	1,202,000											17,080,000	13,611,000	6,514,000	8,065,000	6,768,000	3,109,000
total liabilities	881,394,000	848,958,000	855,167,000	856,579,000	440,143,000	437,711,000	446,823,000	435,203,000	424,869,000	425,742,000	421,547,000	402,435,000	414,376,000	398,752,000	412,858,000	279,051,000	288,242,000	260,131,000	265,490,000	267,481,000	274,047,000	281,061,000	243,998,000	243,645,000	239,250,000	234,678,000	233,341,000	246,978,000	239,067,000	238,375,000	237,382,000	187,668,000	182,673,000	184,926,000	153,216,000	150,549,000	144,223,000	131,410,000	125,183,000	127,383,000	120,621,000	121,245,000	123,924,000				9,325,736		10,922,066	16,373,638	16,578,542		30,742,051	31,233,334	30,669,399	25,619,528	25,459,464	25,157,583	24,310,432	20,606,534											4,299,610	1,705,982	2,325,123	2,790,353	2,755,716
commitments and contingencies
mezzanine equity
convertible preferred stock, series a, 0.0001 par value, 1,666,667 shares authorized; 25,000 shares issued and outstanding at june 30, 2025 and december 31, 2024	24,850,000
stockholders’ equity																																																28,176,000				37,815,000
common stock	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at june 30, 2025 and december 31, 2024, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at june 30, 2025 and december 31, 2024, respectively
treasury stock	-31,594,000	-31,043,000	-21,040,000	-20,722,000	-20,042,000	-18,742,000	-10,081,000	-9,850,000	-9,180,000	-8,643,000	-5,094,000	-4,975,000	-4,736,000	-4,253,000	-3,135,000	-3,135,000	-3,062,000	-2,594,000	-2,246,000	-2,246,000	-2,246,000	-1,211,000	-723,000	-723,000	-723,000		-659,000	-659,000	-659,000	-250,000	-259,000	-259,000	-259,000								-113,000					-68,000
additional paid-in capital	541,899,000	531,055,000	519,653,000	510,899,000	532,497,000	523,628,000	514,103,000	506,513,000	495,488,000	408,395,000	403,901,000	399,396,000	395,043,000	391,084,000	387,844,000	222,211,000	219,403,000	216,223,000	214,354,000	211,792,000	209,409,000	203,505,000	200,800,000	197,470,000	194,867,000	189,971,000	186,812,000	186,532,000	184,531,000	181,649,000	179,020,000	177,436,000	175,901,000	173,989,000	172,563,000	170,665,000	168,154,000	165,681,000	164,431,000	163,118,000	161,397,000	160,095,000	159,509,000	140,221,000	139,070,000	89,501,000
accumulated deficit	-76,862,000	-85,004,000	-100,279,000	-89,597,000	-65,025,000	-62,331,000	-80,132,000	-80,880,000	-90,414,000	-96,252,000	-97,286,000	-92,636,000	-83,630,000	-68,300,000	-47,765,000	-23,439,000	-18,992,000	-4,886,000												-1,756,000	-4,006,000			-1,778,000	-2,916,000	-1,836,000	-4,379,000	-5,504,000	-4,350,000	-7,226,000	-11,785,000	-15,356,000	-19,725,000	-40,730,000	-47,476,000	-48,472,000														-119,434,428						-64,156,187	-54,481,482	-52,807,418	-51,114,374	-48,714,065
accumulated other comprehensive income, net of tax	3,312,000	3,610,000	5,344,000	5,366,000	8,328,000	9,406,000	8,857,000	14,076,000	13,726,000	11,131,000																		533,000	216,000
total stockholders’ equity	436,757,000	418,620,000	403,680,000	405,948,000	455,760,000	451,963,000	432,749,000	429,861,000	409,622,000	314,632,000	313,690,000	311,825,000	312,108,000	321,244,000	333,890,000	191,403,000	191,917,000	203,712,000	195,700,000	195,100,000	191,344,000																												32,289,680							19,147,122
total liabilities, mezzanine equity, and stockholders’ equity	1,343,001,000	1,292,428,000	1,283,697,000	1,287,377,000	920,753,000	914,524,000	904,422,000	889,914,000	859,341,000	765,224,000	760,087,000	739,110,000	751,334,000	744,846,000	771,598,000
accounts receivable, net of 139,655 and 127,824 of adjustments for chargebacks and other allowances at march 31, 2025 and december 31, 2024, respectively		220,334,000
convertible preferred stock, series a, 0.0001 par value, 1,666,667 shares authorized; 25,000 shares issued and outstanding at march 31, 2025 and december 31, 2024		24,850,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at march 31, 2025 and december 31, 2024, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at march 31, 2025 and december 31, 2024, respectively
assets
accounts receivable, net of 127,824 and 97,262 of adjustments for chargebacks and other allowances at december 31, 2024 and 2023, respectively			221,726,000
assets held for sale							8,020,000	8,020,000	8,020,000	8,020,000	8,020,000	8,020,000	8,020,000
convertible preferred stock, series a, 0.0001 par value, 1,666,667 shares authorized; 25,000 shares issued and outstanding at december 31, 2024 and 2023			24,850,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at december 31, 2024 and 2023 respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at december 31, 2024 and 2023, respectively
accounts receivable, net of 91,008 and 97,262 of adjustments for chargebacks and other allowances at september 30, 2024 and december 31, 2023, respectively				196,361,000
prepaid income taxes				6,104,000	2,867,000				4,088,000	3,735,000	3,827,000	3,778,000	2,013,000	1,982,000	3,667,000	3,030,000	2,375,000			1,621,000			1,076,000	814,000	3,442,000				1,734,000	62,000	1,162,000	2,052,000	3,991,000			929,000	150,000	1,150,000	1,127,000	972,000	1,022,000
accrued licensor payment				1,809,000
non-current contingent consideration				20,175,000	11,092,000	11,160,000		10,560,000	12,029,000	13,258,000	35,058,000	33,434,000	30,958,000	32,053,000	31,000,000
accrued licensor payment, net of current				21,316,000
convertible preferred stock, series a, 0.0001 par value, 1,666,667 shares authorized; 25,000 shares issued and outstanding at september 30, 2024 and december 31, 2023				24,850,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at september 30, 2024 and december 31, 2023, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at september 30, 2024 and december 31, 2023, respectively
accounts receivable, net of 102,784 and 97,262 of adjustments for chargebacks and other allowances at june 30, 2024 and december 31, 2023, respectively					166,091,000
convertible preferred stock, series a, 0.0001 par value, 1,666,667 shares authorized; 25,000 shares issued and outstanding at june 30, 2024 and december 31, 2023					24,850,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at june 30, 2024 and december 31, 2023, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at june 30, 2024 and december 31, 2023, respectively
accounts receivable, net of 91,825 and 97,262 of adjustments for chargebacks and other allowances at march 31, 2024 and december 31, 2023, respectively						172,418,000
convertible preferred stock, series a, 0.0001 par value, 1,666,667 shares authorized; 25,000 shares issued and outstanding at march 31, 2024 and december 31, 2023						24,850,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at march 31, 2024 and december 31, 2023, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at march 31, 2024 and december 31, 2023, respectively
current restricted cash											5,006,000
accounts receivable, net of 97,262 and 161,052 of adjustments for chargebacks and other allowances at december 31, 2023 and 2022, respectively							162,079,000
convertible preferred stock, series a, 0.0001 par value, 1,666,667 shares authorized; 25,000 shares issued and outstanding at december 31, 2023 and 2022							24,850,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at december 31, 2023 and 2022 respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at december 31, 2023 and 2022, respectively
accounts receivable, net of 97,774 and 161,052 of adjustments for chargebacks and other allowances at september 30, 2023 and december 31, 2022, respectively								178,842,000
convertible preferred stock, series a, 0.0001 par value, 1,666,667 shares authorized; 25,000 shares issued and outstanding at september 30, 2023 and december 31, 2022								24,850,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at september 30, 2023 and december 31, 2022, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at september 30, 2023 and december 31, 2022, respectively
accounts receivable, net of 89,427 and 161,052 of adjustments for chargebacks and other allowances at june 30, 2023 and december 31, 2022, respectively									172,925,000
convertible preferred stock, series a, 0.0001 par value, 1,666,667 shares authorized; 25,000 shares issued and outstanding at june 30, 2023 and december 31, 2022									24,850,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at june 30, 2023 and december 31, 2022, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at june 30, 2023 and december 31, 2022, respectively

accounts receivable, net of 112,950 and 161,052 of adjustments for chargebacks and other allowances at march 31, 2023 and december 31, 2022, respectively										174,713,000
accumulated depreciation										-27,278,000	-32,712,000	-30,105,000	-27,271,000	-24,964,000	-22,956,000	-21,290,000	-20,002,000	-18,774,000
convertible preferred stock, series a, 0.0001 par value, 1,666,667 shares authorized; 25,000 shares issued and outstanding at march 31, 2023 and december 31, 2022										24,850,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at march 31, 2023 and december 31, 2022, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at march 31, 2023 and december 31, 2022, respectively
accounts receivable, net of 161,052 and 105,260 of adjustments for chargebacks and other allowances at december 31, 2022 and 2021, respectively											165,438,000
non-current restricted cash
derivatives and other non-current liabilities											1,381,000	1,492,000	1,011,000	860,000	7,801,000	8,116,000	9,263,000	8,378,000	14,482,000	16,420,000
convertible preferred stock, series a, 0.0001 par value, 1,666,667 shares authorized; 25,000 shares issued and outstanding at december 31, 2022 and december 31, 2021											24,850,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at december 31, 2022 and december 31, 2021, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at december 31, 2022 and december 31, 2021, respectively
accumulated other comprehensive income/(loss), net of tax											12,168,000	10,039,000	5,430,000	2,712,000
accounts receivable, net of 111,000 and 105,260 of adjustments for chargebacks and other allowances at september 30, 2022 and december 31, 2021, respectively												140,433,000
convertible preferred stock, series a, 0.0001 par value, 1,666,667 shares authorized; 25,000 shares issued and outstanding at september 30, 2022 and december 31, 2021												24,850,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at september 30, 2022 and december 31, 2021, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at september 30, 2022 and december 31, 2021, respectively
accounts receivable, net of 150,428 and 105,260 of adjustments for chargebacks and other allowances at june 30, 2022 and december 31, 2021, respectively													150,410,000
convertible preferred stock, series a, 0.0001 par value, 1,666,667 shares authorized; 25,000 shares issued and outstanding at june 30, 2022 and december 31, 2021													24,850,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at june 30, 2022 and december 31, 2021, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at june 30, 2022 and december 31, 2021, respectively
accounts receivable, net of 113,970 and 105,260 of adjustments for chargebacks and other allowances at march 31, 2022 and december 31, 2021, respectively														131,625,000
deferred revenue														116,000	87,000	62,000	62,000	62,000	80,000	112,000	125,000	318,000	451,000	496,000	558,000	624,000	711,000	735,000																20,000	13,000	47,000																					9,091	18,182	27,273	34,091	68,182	102,273	136,363	136,363	136,363
convertible preferred stock, series a, 0.0001 par value, 1,666,667 shares authorized; 25,000 shares issued and outstanding at march 31, 2022 and december 31, 2021														24,850,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at march 31, 2022 and december 31, 2021, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at march 31, 2022 and december 31, 2021, respectively
accounts receivable, net of 105,260 and 100,328 of adjustments for chargebacks and other allowances at december 31, 2021 and december 31, 2020, respectively															128,526,000
other non-current assets															2,205,000	626,000	720,000	833,000	802,000	985,000	1,095,000	1,110,000	1,220,000	1,656,000	1,789,000	1,903,000
current income taxes payable																		3,659,000	3,906,000		8,286,000	15,223,000				3,453,000	5,022,000	318,000						3,656,000	2,398,000							481,000	4,253,000
convertible preferred stock, series a, 0.0001 par value, 1,666,667 shares authorized; 25,000 shares issued and outstanding at december 31, 2021; 0 shares issued and outstanding at december 31, 2020															24,850,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at december 31, 2021 and december 31, 2020, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at december 31, 2021 and december 31, 2020, respectively
accumulated other comprehensive loss, net of tax															-3,055,000	-4,235,000	-5,433,000	-5,032,000	-11,437,000	-13,110,000	-14,049,000	-11,689,000	-4,871,000	-6,037,000	-5,013,000	-2,199,000	-379,000
accounts receivable, net of 108,456 and 100,328 of adjustments for chargebacks and other allowances at september 30, 2021 and december 31, 2020, respectively																106,714,000
liabilities and stockholders’ equity
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at september 30, 2021 and december 31, 2020, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at september 30, 2021 and december 31, 2020, respectively
total liabilities and stockholders’ equity																470,454,000	480,159,000	463,843,000	461,190,000	462,581,000	465,391,000
accounts receivable, net of 92,130 and 100,328 of adjustments for chargebacks and other allowances at june 30, 2021 and december 31, 2020, respectively																	92,648,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at june 30, 2021 and december 31, 2020, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at june 30, 2021 and december 31, 2020, respectively
accounts receivable, net of 80,722 and 100,328 of adjustments for chargebacks and other allowances at march 31, 2021 and december 31, 2020, respectively																		91,876,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at march 31, 2021 and december 31, 2020, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at march 31, 2021 and december 31, 2020, respectively
accounts receivable, net of 100,328 and 59,946 of adjustments for chargebacks and other allowances at december 31, 2020 and 2019, respectively																			95,793,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at december 31, 2020 and december 31, 2019, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at december 31, 2020 and december 31, 2019, respectively
(accumulated deficit)/retained earnings																			-4,972,000	-1,337,000	-1,771,000
accounts receivable, net of 86,418 and 59,946 of adjustments for chargebacks and other allowances at september 30, 2020 and 2019, respectively																				83,745,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at september 30, 2020 and december 31, 2019, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at september 30, 2020 and december 31, 2019, respectively
accounts receivable, net of 72,469 and 59,946 of adjustments for chargebacks and other allowances at june 30, 2020 and 2019, respectively																					73,162,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at june 30, 2020 and december 31, 2019, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at june 30, 2020 and december 31, 2019, respectively
accounts receivable, net of 104,711 and 59,946 of adjustments for chargebacks and other allowances at march 31, 2020 and december 31, 2019, respectively																						82,379,000
liabilities and stockholders' equity
stockholders' equity
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at march 31, 2020 and december 31, 2019, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at march 31, 2020 and december 31, 2019, respectively
retained earnings																						10,565,000	17,584,000	22,419,000	18,524,000	11,939,000
total stockholders' equity																						201,171,000	212,791,000	213,130,000	207,656,000	199,712,000	197,263,000	192,465,000	185,110,000	179,644,000	174,756,000	182,801,000	176,546,000	172,212,000	169,648,000	168,830,000	163,776,000	160,178,000	160,082,000	155,893,000	149,500,000	144,740,000	139,785,000	99,492,000	91,595,000
total liabilities and stockholders' equity																						482,232,000	456,789,000	456,775,000	446,906,000	434,390,000	430,604,000	439,443,000	424,177,000	418,019,000	412,138,000	370,469,000	359,219,000	357,138,000	322,864,000	319,379,000	307,999,000	291,588,000	285,265,000	283,276,000	270,121,000	265,985,000	263,709,000	107,637,000	95,423,000
accounts receivable, net of 59,946 and 47,705 of adjustments for chargebacks and other allowances at december 31, 2019 and 2018, respectively																							72,129,000
current component of term loan and delayed draw term loan, net of deferred financing costs																							9,941,000
convertible notes, net of discount and deferred financing costs																								117,586,000	115,858,000	114,150,000	112,463,000	134,122,000	132,127,000	130,156,000	128,208,000	126,284,000	124,381,000	122,501,000	120,643,000	118,808,000	116,993,000	115,199,000	113,427,000
term loan and delayed draw term loan, net of deferred financing costs and current component																							175,808,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at december 31, 2019 and 2018, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at december 31, 2019 and 2018, respectively
accounts receivable, net of 47,687 and 47,705 of adjustments for chargebacks and other allowances at september 30, 2019 and december 31, 2018, respectively																								70,700,000
current component of term loan, net of deferred financing costs																								4,154,000	4,149,000
term loan, net of deferred financing costs and current component																								64,873,000	65,688,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at september 30, 2019 and december 31, 2018, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at september 30, 2019 and december 31, 2018, respectively
accounts receivable, net of 46,301 and 47,705 of adjustments for chargebacks and other allowances at june 30, 2019 and december 31, 2018, respectively																									76,274,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at june 30, 2019 and december 31, 2018, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at june 30, 2019 and december 31, 2018, respectively
accounts receivable, net of 48,849 and 47,705 of adjustments for chargebacks and other allowances at march 31, 2019 and december 31, 2018, respectively																										67,410,000
current component of non-current borrowing, net of deferred financing costs																										3,243,000
non-current borrowing, net of deferred financing costs and current borrowing component																										66,501,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at march 31, 2019 and december 31, 2018, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at march 31, 2019 and december 31, 2018, respectively
accounts receivable, net of 47,705 and 34,686 of adjustments for chargebacks and other allowances at december 31, 2018 and 2017, respectively																											64,842,000
other long-term assets																											1,468,000	1,412,000	1,049,000	823,000	829,000
current component of long-term borrowing, net of deferred financing costs																											3,256,000	5,692,000	5,217,000	3,805,000	3,353,000
long-term liabilities
long-term borrowing, net of deferred financing costs and current borrowing component																											67,296,000	65,954,000	67,262,000	68,569,000	69,946,000
other long-term liabilities																											496,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at december 31, 2018 and 2017, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at december 31, 2018 and 2017, respectively
retained earnings/																											11,488,000	6,058,000	1,021,000			5,623,000	903,000
accounts receivable, net of 50,603 and 34,686 of adjustments for chargebacks and other allowances at september 30, 2018 and december 31, 2017, respectively																												67,647,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at september 30, 2018 and december 31, 2017, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at september 30, 2018 and december 31, 2017, respectively
accounts receivable, net of 58,439 and 34,686 of adjustments for chargebacks and other allowances at june 30, 2018 and december 31, 2017, respectively																													56,115,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at june 30, 2018 and december 31, 2017, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at june 30, 2018 and december 31, 2017, respectively
accounts receivable, net of 30,786 and 34,686 of adjustments for chargebacks
and other allowances at march 31, 2018 and december 31, 2017, respectively																														54,801,000
deferred tax asset, net of valuation allowance																														23,163,000	22,667,000	30,829,000	27,933,000	26,962,000	26,227,000	18,400,000	17,751,000	17,397,000	17,316,000		7,027,000	7,369,000	7,796,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at march 31, 2018 and december 31, 2017, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at march 31, 2018 and december 31, 2017, respectively
accounts receivable, net of 34,686 and 31,535 of adjustments for chargebacks and other allowances at december 31, 2017 and 2016, respectively																															58,788,000
long-term royalties																																			625,000	1,250,000	2,500,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at december 31, 2017 and 2016, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at december 31, 2017 and 2016, respectively
accounts receivable, net of 32,463 and 31,535 of adjustments for chargebacks and other allowances at september 30, 2017 and december 31, 2016, respectively																																62,174,000
borrowings on line of credit																																25,000,000	30,000,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at september 30, 2017 and december 31, 2016, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at september 30, 2017 and december 31, 2016, respectively
accounts receivable, net of 39,050 and 31,535 of adjustments for chargebacks and other allowances at june 30, 2017 and december 31, 2016, respectively																																	55,513,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at june 30, 2017 and december 31, 2016, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at june 30, 2017 and december 31, 2016, respectively
accounts receivable, net of 29,481 and 31,535 of adjustments for chargebacks and other allowances at march 31, 2017 and december 31, 2016, respectively																																		46,697,000
line of credit																																		30,000,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at march 31, 2017 and december 31, 2016, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at march 31, 2017 and december 31, 2016, respectively
accounts receivable, net of 31,535 and 13,586 of adjustments for chargebacks and other allowances at december 31, 2016 and 2015, respectively																																			45,895,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at december 31, 2016 and 2015, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at december 31, 2016 and 2015, respectively
accounts receivable, net of 22,385 and 13,586 of adjustments for chargebacks and other allowances at september 30, 2016 and december 31, 2015, respectively																																				47,477,000
accrued medicaid rebates																																				6,451,000	6,509,000	3,424,000	4,631,000	4,428,000	1,891,000	2,077,000	2,264,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at september 30, 2016 and december 31, 2015, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at september 30, 2016 and december 31, 2015, respectively
accounts receivable, net of 23,406 and 13,586 of adjustments for chargebacks and other allowances at june 30, 2016 and december 31, 2015, respectively																																					35,562,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at june 30, 2016 and december 31, 2015, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at june 30, 2016 and december 31, 2015, respectively
accounts receivable, net of 13,630 and 13,586 of adjustments for chargebacks and other allowances at march 31, 2016 and december 31, 2015, respectively																																						22,481,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at march 31, 2016 and december 31, 2015, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at march 31, 2016 and december 31, 2015, respectively
accounts receivable, net of 13,586 and 8,708 of adjustments for chargebacks and other allowances at december 31, 2015 and 2014, respectively																																							21,932,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at december 31, 2015 and 2014, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at december 31, 2015 and 2014, respectively
accounts receivable, net of 9,980 and 8,708 of adjustments for chargebacks and other allowances at september 30, 2015 and december 31, 2014, respectively																																								21,645,000
deferred tax assets, net of valuation allowance																																								8,266,000	7,999,000	7,776,000	7,643,000
deferred financing costs																																								2,674,000	2,885,000	3,096,000	3,307,000
convertible notes, net of discount																																								115,193,000	113,672,000	112,172,000	110,691,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at september 30, 2015 and december 31, 2014, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at september 30, 2015 and december 31, 2014, respectively
accounts receivable, net of 7,724 and 8,708 of adjustments for chargebacks and other allowances at june 30, 2015 and december 31, 2014, respectively																																									18,880,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at june 30, 2015 and december 31, 2014, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at june 30, 2015 and december 31, 2014, respectively
accounts receivable, net of 8,096 and 8,708 of adjustments for chargebacks and other allowances at march 31, 2015 and december 31, 2014, respectively																																										17,371,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at march 31, 2015 and december 31, 2014, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at march 31, 2015 and december 31, 2014, respectively
accounts receivable, net of 8,708 and 5,104 of adjustments for chargebacks and other allowances at december 31, 2014 and 2013, respectively																																											17,297,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at december 31, 2014 and 2013, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at december 31, 2014 and 2013, respectively
accounts receivable, net of 8,100 and 5,104 of allowances for chargebacks and other allowances at september 30, 2014 and december 31, 2013, respectively																																												14,570,000
prepaid expenses																																												599,000	493,000	580,000															1,011,099	836,505
property, plant, and equipment																																												5,046,000	4,625,000
accrued expenses																																												3,888,000	1,133,000	1,326,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at september 30, 2014 and december 31, 2013, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at september 30, 2014 and december 31, 2013, respectively
accounts receivable, net of 7,694 and 5,104 of allowances for chargebacks and other allowances at june 30, 2014 and december 31, 2013, respectively																																													7,794,000
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at june 30, 2014 and december 31, 2013, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at june 30, 2014 and december 31, 2013, respectively
accounts receivable, net of 5,104 and 6,124 of adjustments for chargebacks and other allowances at december 31, 2013 and 2012, respectively																																														12,513,000
deferred loan costs
liabilities and stockholders' equity/
borrowings under line of credit
redeemable convertible preferred stock
stockholders' equity/
class c special stock, 0.0001 par value, 781,281 shares authorized; 10,868 shares issued and outstanding at december 31, 2013 and 2012, respectively
preferred stock, 0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at december 31, 2013 and 2012, respectively
total stockholders' equity/																																														40,962,000
total liabilities and stockholders' equity/																																														44,500,000
prepaid expenses and other assets																																															277,874		534,037	512,640	716,920		943,710	1,013,315	1,137,540		1,150,798	883,188	1,156,514	1,487,160			1,133,012	1,070,051	998,210	677,330	337,420
other assets
investments																																															3,413,762		3,413,762	3,413,762	3,413,762		3,405,807	3,405,807	3,405,807	3,405,807	3,340,000	3,626,000	3,626,000	3,626,000
deposits																																															15,878		30,088	88,793	86,203		86,203	86,203	99,937		99,937	154,937	527,463	652,679	879,956	903,442	637,397	637,397	600,797	573,097	39,536
accrued compensation																																															879,385		463,942	1,031,624	767,672		1,476,036	1,072,972	743,643		1,156,638	887,817	602,346	529,066	759,245	285,084	241,488	290,583	878,555	712,626	717,409	569,831	391,913	289,604	368,522	361,570	324,813	223,579	492,980	493,448
other accrued expenses																																															112,784		860,094	1,028,623	2,035,576		2,747,791	2,872,081	2,235,633		1,415,693	1,082,976	1,608,223	942,922	480,909	865,011	428,905	374,887	266,979	283,849	77,712	68,500	128,500	175,236	65,500	192,651	282,713	104,794	147,125	274,753
current portion of convertible senior notes																																															8,169,215		7,593,216	10,477,635			1,234,000	1,187,497	1,149,820
capital stock
issued and outstanding
2013 - 65,211; 2012 - 65,211 class c special stock																																															391
2013 - 24,422,240; 2012 - 24,422,240 common stock																																															273,277,795
balance sheet data:
cash, cash equivalents and short-term investments																																																34,794,000				57,225,000
convertible senior notes, total long-term																																																				17,337,000
long-term convertible senior notes																																																			10,493,589		19,242,333	19,751,836	18,036,513
2012 - 65,211; 2011 - 65,214 class c special stock																																																	65	65
2012 - 24,422,240; 2011 - 18,269,755 common stock																																																	273,259,171
2012 - 20,137,526 ; 2011 - 18,269,755 common stock																																																		265,768,717
2012 - 391,286; 2011 - 391,286 class c special stock																																																			391
2012 - 120,826,861; 2011 - 109,618,529 common stock																																																			265,499,610
2011 - 391,286; 2010 - 391,286 class c special stock																																																					391	391	391
2011 - 109,618,529; 2010 - 81,391,130 common stock																																																					254,738,709
2011 - 93,600,446; 2010 - 81,391,130 common stock																																																						209,386,676
2011 - 93,590,612; 2010 - 81,391,130 common stock																																																							209,016,797
convertible senior notes due 2013																																																								17,436,201
accounts receivable																																																										53,156	132,748	64,645	38,271	117,333	356,751	229,775	82,531	21,292	14,566	3,599,764	3,577,339	3,514,711	10,510,529
due to licensor - antares																																																											11,889		7,871	16,200	4,887	5,393	4,663	4,972		881,328	898,818	875,000	2,625,000
convertible senior notes due 2011 and 2013																																																									18,364,333	18,467,333	18,085,417	16,676,417
2010 - 391,286; 2009 - 391,286 class c special stock																																																									391	391	391
2010 - 70,802,894; 2009 - 53,262,568 common stock																																																									167,662,306	167,394,417
2010 - 63,667,194; 2009 - 53,262,568 common stock																																																											152,980,145
short-term investments																																																																3,026,334	11,770,374	12,429,841	15,005,976	3,952,633	3,903,529	3,856,965	3,795,977	9,903,757	4,371,626	6,984,609	8,790,888	11,692,960
due to licensor — antares																																																												18,033							1,063
2009 — 391,286; 2008 — 391,286 class c special stock																																																												391
2009 — 53,262,568; 2008 — 27,042,764 common stock																																																												135,264,431
investment in matc																																																													140,000	140,000	140,000	140,000	140,000	140,000	140,000
2009 - 391,286; 2008 - 391,286 class c special stock																																																													391	391	391
2009 - 33,042,764; 2008 - 27,042,764 common stock																																																													98,129,898
deferred acquisition costs																																																														793,398
2009 - 27,042,764; 2008 - 27,042,764 common stock																																																														86,390,531	86,067,964
2008 - 391,286; 2007 - 391,286 class c special stock																																																																391	391	391
2008 - 27,042,764; 2007 - 26,794,607 common stock																																																																85,732,688	85,565,027
accumulated other comprehensive income																																																																	427,500
2008 - 26,881,950; 2007 - 26,794,607 common stock																																																																		84,864,052
see accompanying notes to the condensed financial statements.
benefit from contingencies																																																																						412,941	550,588				750,000
2007-391,286; 2006-391,286 class c special stock																																																																			391
2007-26,794,607; 2006-22,975,040 common stock																																																																			84,206,583
prepaid expenses and other sundry assets																																																																				391,301	208,379	256,521	248,116	270,293	207,678	227,965	245,465	178,455
security deposits																																																																				25,326	25,326	25,326	25,326	25,325	25,325	11,992	11,992
accrual for contingencies																																																																				137,647	275,294			688,234	890,000	890,000
2007 - 391,286; 2006 - 391,286 class c special stock																																																																				391	391	391
2007 - 26,787,273; 2006 - 22,975,040 common stock																																																																				83,987,530
see accompanying notes to the financial statements.
2007 - 26,743,349; 2006 - 22,975,040 common stock																																																																					83,658,695
2007 - 23,027,540; 2006 - 22,975,040 common stock																																																																						65,331,346
long term liabilities
leasehold retirement liability																																																																								43,000	21,500	21,500	21,500
total long term liabilities																																																																								43,000	21,500	55,591	89,682
2006 - 391,286; 2005 - 391,286 class c special stock																																																																							391	398	398	398
2006 - 22,975,040; 2005 - 19,007,800 common stock																																																																							64,967,887	64,915,474
deferred unearned compensation
deficit accumulated during the development stage																																																																								-55,886,776
capital stock issued and outstanding
2006 - 19,160,694; 2005 - 19,007,800 common stock																																																																									57,719,334	57,668,032
due to antares
2005 - 391,286; 2004 - 391,286 class c special stock																																																																											398
2005 - 19,007,800; 2004 - 18,955,181 common stock																																																																											56,653,219
commitments
391,286 (2004 - 391,286) class c special stock																																																																												398
19,007,800 (2004 - 18,955,181) common stock																																																																												56,653,220

We provide you with 20 years of balance sheets for ANI Pharmaceuticals stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ANI Pharmaceuticals. Explore the full financial landscape of ANI Pharmaceuticals stock with our expertly curated balance sheets.

The information provided in this report about ANI Pharmaceuticals stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.